Heinrich Dreser (23 March 1860 – 5 February 1924) was a German chemist who contributed to the early development of pharmaceutical chemistry in the late 19th and early 20th centuries. He is most noted for his work at the Bayer company, where he directed the pharmaceutical laboratory and was involved in research on analgesic and antipyretic agents.
Early Life and Education
- Born in Spangenberg, Hesse, Germany.
- Studied chemistry at the University of Marburg, receiving his doctorate in 1883 with a dissertation on organic compounds.
Career
- Joined the Bayer laboratory in 1884, eventually becoming head of the pharmaceutical department.
- Oversaw the synthesis and commercial production of acetylsalicylic acid (commonly known as aspirin), which Bayer marketed from 1899.
- Conducted research on morphine derivatives, leading to the synthesis of diacetylmorphine (heroin) in 1897; he advocated its use as a cough suppressant and non‑addictive analgesic, a view later contradicted by clinical outcomes.
- Served as a professor of pharmaceutical chemistry at the University of Berlin, lecturing on organic medicinal chemistry.
Scientific Contributions
- Advanced the chemical synthesis techniques for salicylates, improving purity and yield for large‑scale production.
- Published several papers on the pharmacology of alkaloids and synthetic analgesics, influencing contemporary pharmaceutical practices.
Later Life and Legacy
- Retired from Bayer in 1914, continuing academic work until his death in Berlin in 1924.
- Recognized posthumously for his role in establishing systematic pharmaceutical research, though his advocacy for heroin is historically noted as a misjudgment in drug safety.
References
- Bayer corporate archives on the development of aspirin and heroin.
- Historical accounts of German pharmaceutical chemistry, early 20th century.
- University of Berlin faculty records, Department of Pharmaceutical Chemistry.
